机构:[1]Dongguan Institute of Clinical Cancer Research, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, Guangdong, China.[2]Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.[3]Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.[4]Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.广州中医药大学深圳医院深圳市中医院深圳医学信息中心[5]Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.[6]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medicine University, Guangzhou, Guangdong, China.
第一作者机构:[1]Dongguan Institute of Clinical Cancer Research, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, Guangdong, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Kuang Junjie,Zheng Zemao,Ma Wen,et al.Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma[J].FRONTIERS IN PHARMACOLOGY.2023,14:doi:10.3389/fphar.2023.1240736.
APA:
Kuang Junjie,Zheng Zemao,Ma Wen,Zeng Shaohui,Wu Dehua...&Chen Yuming.(2023).Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma.FRONTIERS IN PHARMACOLOGY,14,
MLA:
Kuang Junjie,et al."Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma".FRONTIERS IN PHARMACOLOGY 14.(2023)